ASHI Journal Club #23 - Non-HLA Antibodies Associated with Cardiac Allograft Rejection
Select a ModuleModule DetailsReview MaterialsEvaluate ModulePrint Certificate
- Some transplant recipients suffer rejection in the absence of donor specific antibodies (DSA) to HLA.
- Non-HLA antibodies (Abs) have been associated with an increased risk of acute rejection and chronic allograft injury in transplantation.
- Currently, clinical tests for AT1R, MICA, and unknown endothelial cell membrane antibodies by endothelial cell cross match (ECXM) are available, and a research panel of non-HLA antibodies associated with cardiac allograft rejection has been developed and validated.